Literature DB >> 6222062

Heterogeneity of immunological abnormalities in ataxia-telangiectasia.

M Fiorilli, L Businco, F Pandolfi, R Paganelli, G Russo, F Aiuti.   

Abstract

Peripheral blood mononuclear cells from five patients with ataxia-telangiectasia were evaluated for their reactivity with a panel of monoclonal antibodies directed against T-cell subsets and for their in vitro functions in a pokeweed mitogen-induced immunoglobulin biosynthesis assay. All the patients had significantly reduced proportions of cells identified by monoclonal antibodies to subpopulations of T lymphocytes with helper activity (OKT4 and 5/9) and produced low amounts or no IgA and IgG in vitro. Immunoglobulin biosynthesis was increased by the addition of normal x-irradiated peripheral blood mononuclear cells in one of three patients, suggesting a helper T-cell deficiency in this patient and intrinsic B-cell defects in the other two. Two patients had increased proportions of cells identified by a monoclonal antibody to a subpopulation of T lymphocytes which includes suppressor T cells (OKT8), and their cells were able to suppress immunoglobulin biosynthesis by peripheral blood mononuclear cells from normal donors. These findings indicate heterogeneous disturbances of immunoregulatory mechanisms in ataxia-telangiectasia.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6222062     DOI: 10.1007/bf00915484

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  20 in total

1.  ATAXIA-TELANGIECTASIA. ITS ASSOCIATION WITH A DEFECTIVE THYMUS, IMMUNOLOGICAL-DEFICIENCY DISEASE, AND MALIGNANCY.

Authors:  R D PETERSON; W D KELLY; R A GOOD
Journal:  Lancet       Date:  1964-05-30       Impact factor: 79.321

2.  Immunoglobulin E deficiency in ataxia-telangiectasia.

Authors:  A J Ammann; W A Cain; K Ishizaka; R Hong; R A Good
Journal:  N Engl J Med       Date:  1969-08-28       Impact factor: 91.245

3.  Ataxia-telangiectasia.

Authors:  D E McFarlin; W Strober; T A Waldmann
Journal:  Medicine (Baltimore)       Date:  1972-07       Impact factor: 1.889

4.  Enhancement by irradiated T cells of human plasma cell production: dissection of helper and suppressor functions in vitro.

Authors:  F P Siegal; M Siegal
Journal:  J Immunol       Date:  1977-02       Impact factor: 5.422

5.  The T cell dependence of B cell differentiation induced by pokeweed mitogen.

Authors:  R G Keightley; M D Cooper; A R Lawton
Journal:  J Immunol       Date:  1976-11       Impact factor: 5.422

6.  IgG2 deficiency in ataxia-telangiectasia.

Authors:  V A Oxelius; A I Berkel; L A Hanson
Journal:  N Engl J Med       Date:  1982-03-04       Impact factor: 91.245

7.  T-cell suppression of immunoglobulin synthesis in ataxia telangiectasia: restriction of suppressor activity to B cells from unrelated donors.

Authors:  H Mitsuya; M Matsukura; S Tomino; H Fujiwara; S Kishimoto
Journal:  Clin Immunol Immunopathol       Date:  1981-06

8.  Lymphoid tissue abnormalities associated with ataxia-telangiectasia.

Authors:  R D Peterson; M D Cooper; R A Good
Journal:  Am J Med       Date:  1966-09       Impact factor: 4.965

9.  Discrete stages of human intrathymic differentiation: analysis of normal thymocytes and leukemic lymphoblasts of T-cell lineage.

Authors:  E L Reinherz; P C Kung; G Goldstein; R H Levey; S F Schlossman
Journal:  Proc Natl Acad Sci U S A       Date:  1980-03       Impact factor: 11.205

10.  Human T cell subpopulations defined by a monoclonal antibody. I. A small subset is responsible for proliferation to allogeneic cells or to soluble antigens and for helper activity for B cell differentiation.

Authors:  G Corte; M C Mingari; A Moretta; G Damiani; L Moretta; A Bargellesi
Journal:  J Immunol       Date:  1982-01       Impact factor: 5.422

View more
  14 in total

1.  Selective deficiency of CD4+/CD45RA+ lymphocytes in patients with ataxia-telangiectasia.

Authors:  R Paganelli; E Scala; E Scarselli; C Ortolani; A Cossarizza; D Carmini; F Aiuti; M Fiorilli
Journal:  J Clin Immunol       Date:  1992-03       Impact factor: 8.317

2.  A novel mouse model for ataxia-telangiectasia with a N-terminal mutation displays a behavioral defect and a low incidence of lymphoma but no increased oxidative burden.

Authors:  Andrew Campbell; Brittany Krupp; Jared Bushman; Mark Noble; Christoph Pröschel; Margot Mayer-Pröschel
Journal:  Hum Mol Genet       Date:  2015-08-26       Impact factor: 6.150

3.  Variant of ataxia-telangiectasia with low-level radiosensitivity.

Authors:  M Fiorilli; A Antonelli; G Russo; M Crescenzi; M Carbonari; P Petrinelli
Journal:  Hum Genet       Date:  1985       Impact factor: 4.132

4.  The wasted mutant mouse. II. Immunological abnormalities in a mouse described as a model of ataxia-telangiectasia.

Authors:  D Kaiserlian; W Savino; J Uriel; J Hassid; M Dardenne; J F Bach
Journal:  Clin Exp Immunol       Date:  1986-03       Impact factor: 4.330

5.  Thymopentin treatment of selective IgA deficiency.

Authors:  M Fiorilli; I Quinti; G Russi; R Seminara; B Ensoli; F Aiuti
Journal:  Surv Immunol Res       Date:  1985

Review 6.  Ataxia-telangiectasia and the ATM gene: linking neurodegeneration, immunodeficiency, and cancer to cell cycle checkpoints.

Authors:  Y Shiloh; G Rotman
Journal:  J Clin Immunol       Date:  1996-09       Impact factor: 8.317

7.  Analysis of CD3 antigen expression in patients with ataxia-telangiectasia.

Authors:  B Boutin; D K Wagner; D L Nelson
Journal:  Clin Exp Immunol       Date:  1987-05       Impact factor: 4.330

8.  Deficiencies in CD4+ and CD8+ T cell subsets in ataxia telangiectasia.

Authors:  R Schubert; J Reichenbach; S Zielen
Journal:  Clin Exp Immunol       Date:  2002-07       Impact factor: 4.330

9.  The impact of an early truncating founder ATM mutation on immunoglobulins, specific antibodies and lymphocyte populations in ataxia-telangiectasia patients and their parents.

Authors:  A Stray-Pedersen; T Jónsson; A Heiberg; C R Lindman; E Widing; I S Aaberge; A L Borresen-Dale; T G Abrahamsen
Journal:  Clin Exp Immunol       Date:  2004-07       Impact factor: 4.330

10.  Evidence that defective gamma interferon production in patients with primary immunodeficiencies is due to intrinsic incompetence of lymphocytes.

Authors:  R Paganelli; M R Capobianchi; B Ensoli; G P D'Offizi; J Facchini; F Dianzani; F Aiuti
Journal:  Clin Exp Immunol       Date:  1988-04       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.